Open original FDA record ↗Recall record
- FDA identifier
- Z-0938-2021
- Company in FDA record
- Alung Technologies Inc
- FDA record creation date
- Jan 29, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
CME America BodyGuard 323 Infusion Pumps (recalled by manufacturer) is a component to the Hemolung for EUA, and the infusion pump may have a delivery inaccuracy
Source facts
- Action
- ALung issued email notification "Recalled CME BodyGuard 323 Infusion Pump to Sapphire Pump Exchange" on 12/18/20 . Letter notifies users of the CME/Sapphire Infusion Pump exchange. Provided with this email are the instructions that will come with the infusion pump package. We wanted to give you a preview of what is coming prior to the packages arriving. Once received, we ask that you promptly remove the current CME pump, package and ship back to ALung. These are needed to be returned to the manufacturer by the end of the year. Reminder you may need to contact biomed for the electrical safety testing of the new Sapphire pump! Please follow your internal protocols.
- Initiated
- 2020-12-18
- Root cause
- Nonconforming Material/Component
- Terminated
- 2021-05-17
- Distribution
- US Nationwide distribution.
- Recall number
- Z-0938-2021
- Recall status
- Terminated
- CDRH record ID
- 185129
- FDA record created
- 2021-01-29
- Recall event number
- 87048